The Vietnam Young Physicians Association (VYPA) and AstraZeneca Vietnam have recently launched the “Health Innovation Network” and kick-started the first programme under the network called "Digital Lung Health". 

With the approval of the Ministry of Health, the People's Committee of HCM City, and the Standing Committee of the Vietnam Youth Union, the Health Innovation Network has been jointly developed by the VYPA and AstraZeneca Vietnam. 

The network is a collective effort of individuals and healthcare organisations, contributing intellectual resources and expertise to effectively harness the advancements of the fourth industrial revolution in the areas of healthcare protection, care, and improvement of people's health. 

The programme is coordinated with the HCM City Society of Asthma - Allergy - Clinical Immunology (HSAACI).

"Lung cancer and other lung diseases have emerged as prominent global causes of mortality. Nevertheless, when identified in its early stages, the prospects for effective treatment are significantly improved. Consequently, this screening program assumes paramount importance as it is not only crucial but also indispensable,” stated Dr Hà Anh Đức, chairman of VYPA.

Alongside disease control, the prevention and control of non-communicable diseases are prioritised in Việt Nam's healthcare policies, where scientific research plays a crucial role in providing information and evidence for policy development and finding the most effective measures and interventions to address these diseases. 

On the launching day of the network, a significant number of individuals from various age groups residing in different districts of HCM City gathered for a complimentary medical screening and health consultation programme. 

The event also provided consultations on utilising telehealth applications. Over 150 doctors from reputable hospitals were present to offer their expertise and guidance to city residents. 

From December 2023, the programme will be expanded nationwide, targeting five major cities, including Hà Nội, HCM City, Đà Nẵng, Cần Thơ and Thừa Thiên-Huế. 

Over 60 hospitals are expected to participate with a primary focus on screening for respiratory diseases, including lung cancer, for over 100,000 people. — VNS